Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

O. Akkerman; A. Aleksa; J.-W. Alffenaar; N.H. Al-Marzouqi; M. Arias-Guillén; E. Belilovski; E. Bernal; M.J. Boeree; S.E. Borisov; J. Bruchfeld; J. Cadiñanos Loidi; Q. Cai; J.A. Caminero; J.J. Cebrian Gallardo; R. Centis; L.R. Codecasa; L. D'Ambrosio; M. Dalcolmo; E. Danila; M. Dara; E. Davidavičienė; L. Davies Forsman; J. De Los Rios Jefe; J. Denholm; R. Duarte; S.E. Elamin; M. Ferrarese; A. Filippov; S. Ganatra; A. Garcia; J.-M. García-García; R. Gayoso; A.M. Giraldo Montoya; R.G. Gomez Rosso; G. Gualano; W. Hoefsloot; B. Ilievska-Poposka; J. Jonsson; E. Khimova; L. Kuksa; H. Kunst; R. Laniado-Laborín; Y. Li; C. Magis-Escurra; V. Manfrin; S. Manga; V. Marchese; E. Martínez Robles; A. Maryandyshev; A. Matteelli; G.B. Migliori; J.B. Mullerpattan; M. Munoz-Torrico; H. Mustafa Hamdan; M. Nieto Marcos; N.M. Noordin; D.J. Palmero; F. Palmieri; M.-C. Payen; A. Piubello; E. Pontali; A. Pontarelli; S. Quirós; A. Rendon; A. Skrahina; A. Šmite; I. Solovic; G. Sotgiu; M.B. Souleymane; A. Spanevello; M. Stošić; M. Tadolini; S. Tiberi; Z.F. Udwadia; M. van den Boom; M. Vescovo; P. Viggiani; D. Visca; D. Zhurkin; M. Zignol; The members of the International Study Group on new anti-tuberculosis drugs and adverse events monitoring

doi:10.1016/j.ijid.2019.03.036

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

O. Akkerman, A. Aleksa, J.-W. Alffenaar, N.H. Al-Marzouqi, M. Arias-Guillén, E. Belilovski, E. Bernal, M.J. Boeree, S.E. Borisov, J. Bruchfeld, J. Cadiñanos Loidi, Q. Cai, J.A. Caminero, J.J. Cebrian Gallardo, R. Centis, L.R. Codecasa, L. D'Ambrosio, M. Dalcolmo, E. Danila, M. DaraE. Davidavičienė, L. Davies Forsman, J. De Los Rios Jefe, J. Denholm, R. Duarte, S.E. Elamin, M. Ferrarese, A. Filippov, S. Ganatra, A. Garcia, J.-M. García-García, R. Gayoso, A.M. Giraldo Montoya, R.G. Gomez Rosso, G. Gualano, W. Hoefsloot, B. Ilievska-Poposka, J. Jonsson, E. Khimova, L. Kuksa, H. Kunst, R. Laniado-Laborín, Y. Li, C. Magis-Escurra, V. Manfrin, S. Manga, V. Marchese, E. Martínez Robles, A. Maryandyshev, A. Matteelli, G.B. Migliori, J.B. Mullerpattan, M. Munoz-Torrico, H. Mustafa Hamdan, M. Nieto Marcos, N.M. Noordin, D.J. Palmero, F. Palmieri, M.-C. Payen, A. Piubello, E. Pontali, A. Pontarelli, S. Quirós, A. Rendon, A. Skrahina, A. Šmite, I. Solovic, G. Sotgiu, M.B. Souleymane, A. Spanevello, M. Stošić, M. Tadolini, S. Tiberi, Z.F. Udwadia, M. van den Boom, M. Vescovo, P. Viggiani, D. Visca, D. Zhurkin, M. Zignol, The members of the International Study Group on new anti-tuberculosis drugs and adverse events monitoring

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	72-76
Number of pages	5
Journal	International Journal of Infectious Diseases
Volume	83
DOIs	https://doi.org/10.1016/j.ijid.2019.03.036
Publication status	Published - 2019

Access to Document

10.1016/j.ijid.2019.03.036

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065097630&doi=10.1016%2fj.ijid.2019.03.036&partnerID=40&md5=d0ddfc302fe199126e672c4e95a9eb47

Cite this

Akkerman, O., Aleksa, A., Alffenaar, J-W., Al-Marzouqi, N. H., Arias-Guillén, M., Belilovski, E., Bernal, E., Boeree, M. J., Borisov, S. E., Bruchfeld, J., Cadiñanos Loidi, J., Cai, Q., Caminero, J. A., Cebrian Gallardo, J. J., Centis, R., Codecasa, L. R., D'Ambrosio, L., Dalcolmo, M., Danila, E., ... monitoring, T. M. O. T. I. S. G. O. N. A. D. A. A. E. (2019). Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study. International Journal of Infectious Diseases, 83, 72-76. https://doi.org/10.1016/j.ijid.2019.03.036

Akkerman, O, Aleksa, A, Alffenaar, J-W, Al-Marzouqi, NH, Arias-Guillén, M, Belilovski, E, Bernal, E, Boeree, MJ, Borisov, SE, Bruchfeld, J, Cadiñanos Loidi, J, Cai, Q, Caminero, JA, Cebrian Gallardo, JJ, Centis, R, Codecasa, LR, D'Ambrosio, L, Dalcolmo, M, Danila, E, Dara, M, Davidavičienė, E, Davies Forsman, L, De Los Rios Jefe, J, Denholm, J, Duarte, R, Elamin, SE, Ferrarese, M, Filippov, A, Ganatra, S, Garcia, A, García-García, J-M, Gayoso, R, Giraldo Montoya, AM, Gomez Rosso, RG, Gualano, G, Hoefsloot, W, Ilievska-Poposka, B, Jonsson, J, Khimova, E, Kuksa, L, Kunst, H, Laniado-Laborín, R, Li, Y, Magis-Escurra, C, Manfrin, V, Manga, S, Marchese, V, Martínez Robles, E, Maryandyshev, A, Matteelli, A, Migliori, GB, Mullerpattan, JB, Munoz-Torrico, M, Mustafa Hamdan, H, Nieto Marcos, M, Noordin, NM, Palmero, DJ, Palmieri, F, Payen, M-C, Piubello, A, Pontali, E, Pontarelli, A, Quirós, S, Rendon, A, Skrahina, A, Šmite, A, Solovic, I, Sotgiu, G, Souleymane, MB, Spanevello, A, Stošić, M, Tadolini, M, Tiberi, S, Udwadia, ZF, van den Boom, M, Vescovo, M, Viggiani, P, Visca, D, Zhurkin, D, Zignol, M & monitoring, TMOTISGONADAAE 2019, 'Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study', International Journal of Infectious Diseases, vol. 83, pp. 72-76. https://doi.org/10.1016/j.ijid.2019.03.036

@article{a53c076fdcde4ced8f218c75101e92cf,

title = "Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study",

author = "O. Akkerman and A. Aleksa and J.-W. Alffenaar and N.H. Al-Marzouqi and M. Arias-Guill{\'e}n and E. Belilovski and E. Bernal and M.J. Boeree and S.E. Borisov and J. Bruchfeld and {Cadi{\~n}anos Loidi}, J. and Q. Cai and J.A. Caminero and {Cebrian Gallardo}, J.J. and R. Centis and L.R. Codecasa and L. D'Ambrosio and M. Dalcolmo and E. Danila and M. Dara and E. Davidavi{\v c}ienė and {Davies Forsman}, L. and {De Los Rios Jefe}, J. and J. Denholm and R. Duarte and S.E. Elamin and M. Ferrarese and A. Filippov and S. Ganatra and A. Garcia and J.-M. Garc{\'i}a-Garc{\'i}a and R. Gayoso and {Giraldo Montoya}, A.M. and {Gomez Rosso}, R.G. and G. Gualano and W. Hoefsloot and B. Ilievska-Poposka and J. Jonsson and E. Khimova and L. Kuksa and H. Kunst and R. Laniado-Labor{\'i}n and Y. Li and C. Magis-Escurra and V. Manfrin and S. Manga and V. Marchese and {Mart{\'i}nez Robles}, E. and A. Maryandyshev and A. Matteelli and G.B. Migliori and J.B. Mullerpattan and M. Munoz-Torrico and {Mustafa Hamdan}, H. and {Nieto Marcos}, M. and N.M. Noordin and D.J. Palmero and F. Palmieri and M.-C. Payen and A. Piubello and E. Pontali and A. Pontarelli and S. Quir{\'o}s and A. Rendon and A. Skrahina and A. {\v S}mite and I. Solovic and G. Sotgiu and M.B. Souleymane and A. Spanevello and M. Sto{\v s}i{\'c} and M. Tadolini and S. Tiberi and Z.F. Udwadia and {van den Boom}, M. and M. Vescovo and P. Viggiani and D. Visca and D. Zhurkin and M. Zignol and monitoring, {The members of the International Study Group on new anti-tuberculosis drugs and adverse events}",

note = "Cited By :5 Export Date: 14 February 2020",

year = "2019",

doi = "10.1016/j.ijid.2019.03.036",

language = "English",

volume = "83",

pages = "72--76",

journal = "International Journal of Infectious Diseases",

issn = "1201-9712",

publisher = "Elsevier",

}

TY - JOUR

T1 - Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

AU - Akkerman, O.

AU - Aleksa, A.

AU - Alffenaar, J.-W.

AU - Al-Marzouqi, N.H.

AU - Arias-Guillén, M.

AU - Belilovski, E.

AU - Bernal, E.

AU - Boeree, M.J.

AU - Borisov, S.E.

AU - Bruchfeld, J.

AU - Cadiñanos Loidi, J.

AU - Cai, Q.

AU - Caminero, J.A.

AU - Cebrian Gallardo, J.J.

AU - Centis, R.

AU - Codecasa, L.R.

AU - D'Ambrosio, L.

AU - Dalcolmo, M.

AU - Danila, E.

AU - Dara, M.

AU - Davidavičienė, E.

AU - Davies Forsman, L.

AU - De Los Rios Jefe, J.

AU - Denholm, J.

AU - Duarte, R.

AU - Elamin, S.E.

AU - Ferrarese, M.

AU - Filippov, A.

AU - Ganatra, S.

AU - Garcia, A.

AU - García-García, J.-M.

AU - Gayoso, R.

AU - Giraldo Montoya, A.M.

AU - Gomez Rosso, R.G.

AU - Gualano, G.

AU - Hoefsloot, W.

AU - Ilievska-Poposka, B.

AU - Jonsson, J.

AU - Khimova, E.

AU - Kuksa, L.

AU - Kunst, H.

AU - Laniado-Laborín, R.

AU - Li, Y.

AU - Magis-Escurra, C.

AU - Manfrin, V.

AU - Manga, S.

AU - Marchese, V.

AU - Martínez Robles, E.

AU - Maryandyshev, A.

AU - Matteelli, A.

AU - Migliori, G.B.

AU - Mullerpattan, J.B.

AU - Munoz-Torrico, M.

AU - Mustafa Hamdan, H.

AU - Nieto Marcos, M.

AU - Noordin, N.M.

AU - Palmero, D.J.

AU - Palmieri, F.

AU - Payen, M.-C.

AU - Piubello, A.

AU - Pontali, E.

AU - Pontarelli, A.

AU - Quirós, S.

AU - Rendon, A.

AU - Skrahina, A.

AU - Šmite, A.

AU - Solovic, I.

AU - Sotgiu, G.

AU - Souleymane, M.B.

AU - Spanevello, A.

AU - Stošić, M.

AU - Tadolini, M.

AU - Tiberi, S.

AU - Udwadia, Z.F.

AU - van den Boom, M.

AU - Vescovo, M.

AU - Viggiani, P.

AU - Visca, D.

AU - Zhurkin, D.

AU - Zignol, M.

AU - monitoring, The members of the International Study Group on new anti-tuberculosis drugs and adverse events

N1 - Cited By :5 Export Date: 14 February 2020

PY - 2019

Y1 - 2019

U2 - 10.1016/j.ijid.2019.03.036

DO - 10.1016/j.ijid.2019.03.036

M3 - Article

SN - 1201-9712

VL - 83

SP - 72

EP - 76

JO - International Journal of Infectious Diseases

JF - International Journal of Infectious Diseases

ER -